BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12696176)

  • 1. [A case of drug induced liver injury related pioglitazone].
    Hisamochi A; Kumashiro R; Koga Y; Tanaka E; Ide T; Hino T; Murashima S; Ogata K; Kuwahara R; Koga H; Shishido S; Ueno T; Sata M; Eguchi T
    Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):333-6. PubMed ID: 12696176
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular injury in a patient receiving pioglitazone.
    Maeda K
    Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
    [No Abstract]   [Full Text] [Related]  

  • 3. Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.
    Ann Intern Med; 2002 Mar; 136(6):I65. PubMed ID: 11900516
    [No Abstract]   [Full Text] [Related]  

  • 4. "Did this drug cause my patient's hepatitis?" and related questions.
    Nierenberg DW
    Ann Intern Med; 2002 Mar; 136(6):480-3. PubMed ID: 11900502
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe but reversible cholestatic liver injury after pioglitazone therapy.
    Pinto AG; Cummings OW; Chalasani N
    Ann Intern Med; 2002 Nov; 137(10):857. PubMed ID: 12435231
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pioglitazone].
    Kobayashi M; Iwata M; Hiratani K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
    [No Abstract]   [Full Text] [Related]  

  • 10. What caused this patient's sudden liver dysfunction?
    Porterfield LM
    RN; 2001 Mar; 64(3):98. PubMed ID: 11288655
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic injury due to troglitazone.
    Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
    Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
    [No Abstract]   [Full Text] [Related]  

  • 12. Angioneurotic edema as a side effect of pioglitazone.
    Shadid S; Jensen MD
    Diabetes Care; 2002 Feb; 25(2):405. PubMed ID: 11815525
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does pioglitazone, like troglitazone, increase serum levels of lipoprotein(a) in diabetic patients?
    Nagai Y; Abe T; Nomura G
    Diabetes Care; 2001 Feb; 24(2):408-9. PubMed ID: 11213903
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe but reversible hepatitis induced by troglitazone.
    Schiano T; Dolehide K; Hart J; Baker AL
    Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-onset troglitazone-induced hepatic dysfunction.
    Bell DS; Ovalle F
    Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
    [No Abstract]   [Full Text] [Related]  

  • 17. Substituting for troglitazone (Rezulin).
    Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meta-analysis shows: insulin sensitizer is safe for the liver].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA reviews troglitazone.
    Donnelly R
    Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.